The Prevalence and Risk Factors of Sexual Dysfunction in Gynaecological Cancer Patients
Sexual Dysfunction in Gynaecological Cancer Patients
Vol. 9 No. 1 : 2014 (53-61)
Abstract
Sexual dysfunction is highly prevalent in gynaecological cancer patients. Most of the time, sexual dysfunction in gynaecological cancer is underdiagnosed as there is overlapping of symptoms with other psychological morbidities, interplaying of multiple risks, patients’ reluctance to complain or incompetence of health care provider to assess. Determining the risk factors of sexual dysfunction in cancer patients enables us to pay more attention to those who are vulnerable and to device strategies for early detection, prevention and treatment of sexual dysfunction in them. The main aim of the study was to determine the prevalence of sexual dysfunction and its risk factors in gynaecological cancer patients in Hospital Sultanah Bahiyah, Alor Star, Malaysia. Sexual function of eighty-three gynaecological cancer patients who were married were assessed with self-rated MVFSFI (Malay version Female Sexual Function Index). Self-rated WHOQOL-BREF (World Health Organization- Quality of Life- 26) which assessed the domains of quality of life was used while MINI (Mini International Neuropsychiatry Interview) was used for diagnosis of major depressive disorder. The prevalence of sexual dysfunction among the married gynaecological cancer patients was 65% (54/83). Sexual dysfunction was significantly associated with low education level (OR 3.055, CI 1.009-9.250), shorter duration of cancer (OR 0.966, CI 0.966- 0.998), ongoing chemotherapy (OR 3.045, CI 1.149-8.067), pain perception (OR 3.230, CI 1.257-8.303), absence of sexual intercourse for more than one month (OR 1.862) and three domains of quality of life such as physical health, psychological health and social relationship (OR 0.942, CI 0.908-0.978; OR 0.955, CI 0.916-0.995; OR 0.933, CI 0.894-0.973, respectively). However, sexual dysfunction was not associated with major depressive disorder (χ2² = 1.224, p = 0.268). The prevalence of sexual dysfunction in gynaecological cancer patients was comparable to other studies of similar population. Since, the risk factors of sexual dysfunction in gynaecological cancer patients are multidimensional, the process of assessment and management need to be holistic and patient-oriented.
Keywords :
gynaecological cancer,
quality of life,
risk factors,
sexual dysfunction,
Correspondance Address
Prof. Dr. Hatta Sidi, Department of Psychiatry, Faculty of Medicine, Universiti Kebangsaan Malaysia Medical Center, Jalan Yaacob Latif, Bandar Tun Razak, 56000 Cheras, Kuala Lumpur, Malaysia. Tel: +603-91456142 Fax: +603-91456681 Email: hattasidi@hotmail.com
References
American Psychiatric Association. 1994. Diagnostic and statistical manual of mental disorders DSM-IV, 4th edition. Washington: American Psychiatric Association. http://justines2010blog.files.wordpress.com/2011/03/dsm-iv.pdf [9 May 2014].
Amsterdam, A., Krychman, M. 2008. Sexual Function in Gynecologic Cancer Survivors. Expert Rev Obstet Gynecol 3(3): 331-7.
Anderson, B.L. 1990. How cancer affects sexual functioning. Oncology 4: 81-94.
Anderson, B.L. 1999. Surviving cancer: the importance of sexual self-concept. Med Pediatr Oncol 33(1): 5-23.
Auchincloss, S.S., McCartney, C.F. 1998. Gynecologic cancer. In: Psych-oncology. Edited by Holland JC. Breitbart W, Jacobsen PB, Lederberg MS, Loscalzo M, Massie MJ, McCorkle R. New York: Oxford University Press; 359-70.
Brock, G., Laumann, E., Glasser, D.B., Nicolosi, A., Gingell, C., King, R. 2003. Prevalence of sexual dysfunction among mature men and women in USA, Canada, Australia and New Zealand. Journal of Urology 163: 888-93.
Broeckel, J.A., Thors, C.L., Jacobsen, P.B., Small, M., Cox, C.E. 2002. Sexual functioning in long-term breast cancer survivors treated with adjuvant chemotherapy. Breast Cancer Res Treat 75(3): 241-8.
Casey, C. 1996. Psychosexual morbidity following gynaecological malignancy. Ir Med J
89(6): 200-2.
Ganz, P.A., Rowland, J.H., Desmond, K., Meyerowitz, B.E., Wyatt, G.E. 1998. Life after breast cancer: understanding women’s health-related quality of life and sexual functioning. J Clin Oncol 16(2): 501-4.
Hasanah, C.I., Naing, L., Rahman, A.R. 2003. World Health Organization Quality of life Assessment: brief version in Bahasa Malaysia. Med J Malaysia 58(1): 79-88.
Laumann, E.O., Paik, A., Rosen, R.C. 1999. Sexual dysfunction in United States: prevalence and predictors. JAMA 281(6): 537-44.
Lim, G.C.C., Halimah, Y. 2004. Cancer Incidence in Malaysia 2003. Second Report of the National Cancer Registry. Kuala Lumpur: National Cancer Registry. http://www.crc.gov.my/wp-content/uploads/documents/report/2nd%20National%20Cancer%20Registry.pdf [9 May 2014].
Marwick, C. 1999. Survey says patients expect little physician help on sex. JAMA 281(23): 2173–4.
Nicolosi, A., Glasser, D.B., Kim, S.C., Marumo, K., Laumann, E.O. 2005. Sexual behaviour and dysfunction and help-seeking patterns in adults aged 40-80 years in the urban population of Asian countries. BJU Int 95(4): 609-14.
Schover, L.R. 1997. Sexuality and Fertility after Cancer. New York: John Wiley and Sons; 5-10.
Schover, L.R., Jensen, S.B. 1998. Sexuality and chronic illness: A comprehensive approach. New York: Guilford Press; 10-20.
Sheehan, D.V., Lecrubier, Y., Sheehan, K.H., Amorim, P., Janavs, J., Weiller, E., Hergueta, T., Baker, R., Dunbar, G.C. 1998. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59(suppl 20): 20-33.
Sidi, H., Abdullah, N., Puteh, S.E., Midin, M. 2007. The Female Sexual Function (FSFI): validation of the Malay version. J Sex Med 4(6): 1642-54.
Taylor, E.J. 2000. Transformation of tragedy among women surviving breast cancer. Oncol Nurs Forum 27(5): 781-8.
